Shots into the tumor to boost the immune system
Part of Cancer, Digestive system, Lungs & breathing clinical trials.
This Phase 1 study tests an injection given directly into an advanced solid tumor to help the immune system better recognize and attack cancer. It may help people with advanced solid tumors, but the goal at this early stage is mainly to check safety and how the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an advanced solid (solid, not blood) cancer
- You are between 18 and 80 years old
- Your estimated life expectancy is more than 3 months
- Your tumor is not benign (it must be cancer, not a non-cancer growth)
- You do not have serious other medical conditions that could make treatment unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a treatment where drug-loaded tiny beads are injected into a solid tumor, using more than one medicine. It may help people with advanced solid cancers by delivering the drugs right at the tumor site.
This study uses a personalized cell therapy called tumor polypeptide DC-CTL to try to boost your immune system to fight solid tumors. It is for people with cancers like colorectal, lung, or breast cancer who need additional treatment.
This trial tests an investigational injection (OH2) that goes directly into tumors. It may help shrink tumors and control cancer in people with certain advanced solid tumors who have run out of other options.
This Phase 1/2 study tests a medicine injected directly into a tumor, alone or with pembrolizumab (an immune-therapy drug given through a vein). It is for people with advanced or metastatic solid cancers that have grown despite standard treatments, aiming to improve tumor control.
This trial tests a new treatment where a virus (GC001) is injected directly into a tumor. The virus is designed to attack cancer cells and may help people with advanced solid tumors that haven't responded to other treatments.
This early-phase study tests a medicine called SGN1 given directly into a solid tumor. It’s for people with advanced cancers that have not responded to standard treatment (or don’t have good standard options) and aims to see if the injection is safe and may work.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.